![](/img/cover-not-exists.png)
Safety, tolerability, and immunogenicity of a recombinant toxic shock syndrome toxin (rTSST)-1 variant vaccine: a randomised, double-blind, adjuvant-controlled, dose escalation first-in-man trial
Schwameis, Michael, Roppenser, Bernhard, Firbas, Christa, Gruener, Corina S, Model, Nina, Stich, Norbert, Roetzer, Andreas, Buchtele, Nina, Jilma, Bernd, Eibl, Martha MLanguage:
english
Journal:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(16)30115-3
Date:
June, 2016
File:
PDF, 381 KB
english, 2016